dc.contributor.author | ABACI, Ayhan | |
dc.contributor.author | Siklar, Zeynep | |
dc.contributor.author | Genens, Mikayir | |
dc.contributor.author | Bundak, Ruveyde | |
dc.contributor.author | Cetinkaya, Semra | |
dc.contributor.author | ATAY, Zeynep | |
dc.contributor.author | Turan, Serap | |
dc.contributor.author | Kara, Cengiz | |
dc.contributor.author | Yilmaz, Gulay Can | |
dc.contributor.author | Akyurek, Nesibe | |
dc.contributor.author | Celmeli, Gamze | |
dc.contributor.author | Sari, Erkan | |
dc.contributor.author | BOLU, Semih | |
dc.contributor.author | Korkmaz, Huseyin Anil | |
dc.contributor.author | SIMSEK, Enver | |
dc.contributor.author | CATLI, Gonul | |
dc.contributor.author | Buyukinan, Muammer | |
dc.contributor.author | CAYIR, Atilla | |
dc.contributor.author | Isguven, Pinar | |
dc.contributor.author | Ozgen, Tolga | |
dc.contributor.author | Hatipoglu, Nihal | |
dc.contributor.author | Elhan, Atilla Halil | |
dc.contributor.author | Berberoglu, Merih | |
dc.contributor.author | Evliyaoglu, Olcay | |
dc.contributor.author | Erdeve, Senay Savas | |
dc.contributor.author | Aycan, Zehra | |
dc.contributor.author | Darendeliler, Fatma Feyza | |
dc.contributor.author | Bas, Firdevs | |
dc.contributor.author | Guven, Ayla | |
dc.contributor.author | Poyrazoglu, Sukran | |
dc.contributor.author | Abali, Saygın | |
dc.date.accessioned | 2021-03-03T13:10:47Z | |
dc.date.available | 2021-03-03T13:10:47Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Siklar Z., Genens M., Poyrazoglu S., Bas F., Darendeliler F. F. , Bundak R., Aycan Z., Erdeve S. S. , Cetinkaya S., Guven A., et al., "The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.", Journal of clinical research in pediatric endocrinology, cilt.8, sa.3, ss.305-12, 2016 | |
dc.identifier.issn | 1308-5727 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_32740539-2493-4150-b47b-d8b5a02dfd52 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/38256 | |
dc.identifier.uri | https://doi.org/10.4274/jcrpe.3013 | |
dc.description.abstract | Objective: Noonan syndrome (NS) is a multisystem disorder, and short stature is its most striking manifestation. Optimal growth hormone (GH) treatment for NS is still controversial. In this study, using a nationwide registration system, we aimed to evaluate the growth characteristics and the clinical features of NS patients in Turkey and their growth response to GH treatment. | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | PEDİATRİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Çocuk Sağlığı ve Hastalıkları | |
dc.subject | İç Hastalıkları | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.title | The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study. | |
dc.type | Makale | |
dc.relation.journal | Journal of clinical research in pediatric endocrinology | |
dc.contributor.department | Ankara Üniversitesi , , | |
dc.identifier.volume | 8 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 305 | |
dc.identifier.endpage | 12 | |
dc.contributor.firstauthorID | 50700 | |